Search all medical codes

Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela

ICD10CM code

Medical Policies and Guidelines for Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela

Related policies from health plans

Transthoracic Echocardiography in Children - (0523)

Similar Codes


ICD10CM codes

T50.2X5S - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
T50.2X5 - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
T50.2X5D - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent e
T50.2X6S - Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
T50.2X5A - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial enco
T50.2X1S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unint
T50.2X3S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, sequela
T50.2X4S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, seq
T50.2X2S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-
T50.2X - Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides

HCPCS codes

G8506 - Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb
G8935 - Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (
G8473 - Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescrib
G8474 - Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not pres
J1120 - Injection, acetazolamide sodium, up to 500 mg
G8950 - Pre-hypertensive or hypertensive blood pressure reading documented, and the indicated follow-up is d
G9744 - Patient not eligible due to active diagnosis of hypertension
J3265 - Injection, torsemide, 10 mg/ml
G8082 - End stage renal disease patient requiring hemodialysis documented to have received vascular access o
S0039 - Injection, sulfamethoxazole and trimethoprim, 10 ml

CPT4 codes

5010F - Findings of dilated macular or fundus exam communicated to the physician or other qualified health c
82374 - Carbon dioxide (bicarbonate)
78708 - Kidney imaging morphology; with vascular flow and function, single study, with pharmacological inter
82163 - Angiotensin II
0513F - Elevated blood pressure plan of care documented (CKD)
3066F - Documentation of treatment for nephropathy (eg, patient receiving dialysis, patient being treated fo
78709 - Kidney imaging morphology; with vascular flow and function, multiple studies, with and without pharm
80161 - Carbamazepine; -10,11-epoxide
85305 - Clotting inhibitors or anticoagulants; protein S, total
4010F - Angiotensin Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) therapy prescrib